Former Seagen CEO David Epstein to lead new biotech with VEGF bifunctional antibodynews2024-10-28T11:29:10+00:00October 28th, 2024|Endpoints News|
FogPharma rebrands as Parabilis, highlighting next drugsnews2024-10-28T11:00:44+00:00October 28th, 2024|Endpoints News|
